These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27013200)

  • 1. Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway.
    Mo D; Fang H; Niu K; Liu J; Wu M; Li S; Zhu T; Aleskandarany MA; Arora A; Lobo DN; Madhusudan S; Balajee AS; Chi Z; Zhao Y
    Cancer Res; 2016 May; 76(10):3057-66. PubMed ID: 27013200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between PDCD4 and YB1 is critical for cervical cancer stemness and cisplatin resistance.
    Liu D; Ke J; Liu Y; Rao H; Tang Z; Liu Y; Zhang Z; You L; Luo X; Sun Z; He Z; Li F; Qiu Z; Hu J; Mbadhi MN; Tang J; Wu F; Li S
    Mol Carcinog; 2021 Dec; 60(12):813-825. PubMed ID: 34499772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RecQ-like helicase 4 (RECQL4) exacerbates resistance to oxaliplatin in colon adenocarcinoma via activation of the PI3K/AKT signaling pathway.
    Zhou F; Wang L; Jin K; Wu Y
    Bioengineered; 2021 Dec; 12(1):5859-5869. PubMed ID: 34477047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of integrin-linked kinase in multi-drug resistance of human gastric carcinoma SGC7901/DDP cells.
    Song W; Jiang R; Zhao CM
    Asian Pac J Cancer Prev; 2012; 13(11):5619-25. PubMed ID: 23317227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
    BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression.
    Huang YS; Xue Z; Zhang H
    Med Oncol; 2015 Feb; 32(2):470. PubMed ID: 25579168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line.
    Tang T; Song X; Liu YF; Wang WY
    Cell Biol Int; 2014 Apr; 38(4):502-10. PubMed ID: 23956061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufalin reverses intrinsic and acquired drug resistance to cisplatin through the AKT signaling pathway in gastric cancer cells.
    Zhao H; Zhao D; Jin H; Li H; Yang X; Zhuang L; Liu T
    Mol Med Rep; 2016 Aug; 14(2):1817-22. PubMed ID: 27357249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
    Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
    Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway.
    Park J; Ko YS; Yoon J; Kim MA; Park JW; Kim WH; Choi Y; Kim JH; Cheon Y; Lee BL
    Gastric Cancer; 2014; 17(3):423-30. PubMed ID: 24202965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax.
    Kim CW; Lu JN; Go SI; Jung JH; Yi SM; Jeong JH; Hah YS; Han MS; Park JW; Lee WS; Min YJ
    Int J Oncol; 2013 Nov; 43(5):1495-502. PubMed ID: 23970333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-induced killer cells induce apoptosis and inhibit the Akt/nuclear factor-κB signaling pathway in cisplatin-resistant human glioma U87MG cells.
    Cui Y; Yang F; He L
    Mol Med Rep; 2015 Nov; 12(5):7027-32. PubMed ID: 26299434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
    Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
    Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
    Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RecQ protein-like 4 drives cisplatin chemosensitivity of cervical cancer cells by modulating annexin A2.
    Wang R; Zhang Y
    Drug Dev Res; 2024 Nov; 85(7):e70003. PubMed ID: 39404003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib enhanced the cytotoxic effect of cisplatin in drug-resistant human gastric cancer cells by inhibition of cyclooxygenase-2.
    Xu HB; Shen FM; Lv QZ
    Eur J Pharmacol; 2015 Dec; 769():1-7. PubMed ID: 26407653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calycosin Enhances Some Chemotherapeutic Drugs Inhibition of Akt Signaling Pathway in Gastric Cells.
    Zhou L; Wu Y; Guo Y; Li Y; Li N; Yang Y; Qin X
    Cancer Invest; 2017 May; 35(5):289-300. PubMed ID: 28368679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.